These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1547026)

  • 1. TNF-alpha failed to reverse the M. leprae-induced defective chemiluminescence response of human mononuclear cells.
    Launois P; Niang M; Dieye A; Sarthou JL
    FEMS Microbiol Immunol; 1992 Jan; 4(2):91-6. PubMed ID: 1547026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human phagocyte respiratory burst by Mycobacterium bovis BCG and M. leprae: functional activation by BCG is mediated by complement and its receptors on monocytes.
    Launois P; Niang M; Dieye A; Sarthou JL; Rivier F; Millan J
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):225-33. PubMed ID: 1522364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenolic glycolipid-1 from M. leprae inhibits oxygen free radical production by human mononuclear cells.
    Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Bach MA
    Res Immunol; 1989; 140(9):847-55. PubMed ID: 2697907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
    Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human phagocyte oxidative burst activation by BCG, M. leprae, and atypical mycobacteria: defective activation by M. leprae is not reversed by interferon gamma.
    Launois P; Maillere B; Dieye A; Sarthou JL; Bach MA
    Cell Immunol; 1989 Nov; 124(1):168-74. PubMed ID: 2509079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium bovis BCG but not Mycobacterium leprae induces TNF-alpha secretion in human monocytic THP-1 cells.
    Oliveira MM; Charlab R; Pessolani MC
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):973-8. PubMed ID: 11685264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human phagocytic cell responses to Mycobacterium leprae and Mycobacterium bovis Bacillus Calmette-Guérin. An in vitro comparison of leprosy vaccine components.
    Holzer TJ; Kizlaitis L; Vachula M; Weaver CW; Andersen BR
    J Immunol; 1988 Sep; 141(5):1701-8. PubMed ID: 3137262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential production of interleukin 1 (IL-1), IL-6, tumor necrosis factor, and IL-1 receptor antagonist by human monocytes stimulated with Mycobacterium leprae and M. bovis BCG.
    Suzuki K; Fukutomi Y; Matsuoka M; Torii K; Hayashi H; Takii T; Oomoto Y; Onozaki K
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):609-18. PubMed ID: 8151194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of killed Mycobacterium leprae and other mycobacteria on opsonized yeast phagocytosis.
    Cree IA; Beck JS
    Clin Exp Immunol; 1986 Apr; 64(1):35-40. PubMed ID: 3524918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha.
    Hernandez MO; Neves I; Sales JS; Carvalho DS; Sarno EN; Sampaio EP
    Immunology; 2003 May; 109(1):156-64. PubMed ID: 12709029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dharmendra antigen but not integral M. leprae is an efficient inducer of immunostimulant cytokine production by human monocytes, and M. leprae lipids inhibit the cytokine production.
    Nakamura C; Fukutomi Y; Kashiwabara Y; Oomoto Y; Kojima M; Hayashi H; Onozaki K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):63-72. PubMed ID: 9207755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
    Santos DO; Suffys PN; Bonifácio K; Marques MA; Sarno EN
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of soluble receptor for tumor necrosis factor alpha induced by M. leprae or LPS from human mononuclear cells.
    Santos DO; Lorré K; de Boer M; Van Heuverswyn H
    Nihon Hansenbyo Gakkai Zasshi; 1999 Nov; 68(3):185-93. PubMed ID: 10659614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological responsiveness to M. leprae and BCG antigens in 98 leprosy patients and their household contacts.
    Sarno EN; Espinosa M; Sampaio EP; Vieira LM; Figueiredo AA; Miranda CF; Esquenazi D; Salgado JL; Nogueira N
    Braz J Med Biol Res; 1988; 21(3):461-70. PubMed ID: 3147795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.
    Smelt AH; Liew FY; Rees RJ
    Clin Exp Immunol; 1978 Nov; 34(2):164-9. PubMed ID: 367652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
    Tadesse A; Taye E; Sandoval F; Shannon EJ
    Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
    Bjune G
    Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.